82 FR 47537 - National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health

Federal Register Volume 82, Issue 196 (October 12, 2017)

Page Range		47537-47537
FR Document		2017-21989

Federal Register, Volume 82 Issue 196 (Thursday, October 12, 2017)

[Federal Register Volume 82, Number 196 (Thursday, October 12, 2017)]
[Notices]
[Page 47537]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-21989]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Alcohol Abuse and Alcoholism; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism, Special Emphasis Panel; NIAAA Fellowship Review.
    Date: November 2, 2017.
    Time: 8:30 a.m. to 6:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on 
Alcohol Abuse and Alcoholism, Terrace Conference Room, 5635 Fishers 
Lane, Bethesda, MD 20892.
    Contact Person: Richard A. Rippe, Ph.D., Scientific Review 
Officer, Extramural Project Review Branch, Office of Extramural 
Activities, National Institute on Alcohol Abuse and Alcoholism, 
National Institutes of Health, 5635 Fishers Lane, Room 2109, 
Rockville, MD 20852 301-443-8599, rippera@mail.nih.gov.
    This notice is being published less than 15 days prior to the 
meeting due to the timing limitations imposed by the review and 
funding cycle.

    Name of Committee: National Institute on Alcohol Abuse and 
Alcoholism Special Emphasis Panel, SEP Review Member Conflict 
Applications.
    Date: November 14, 2017.
    Time: 2:00 p.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: National Institutes of Health, National Institute on 
Alcohol Abuse and Alcoholism, 5635 Fishers Lane, Rockville, MD 20892 
(Telephone Conference Call).
    Contact Person: Anna Ghambaryan, M.D., Scientific Review 
Officer, Office of Extramural Activities, National Institute on 
Alcohol Abuse and Alcoholism, National Institutes of Health, 5635 
Fishers Lane, Rockville, MD 20852, 301-443-4032, 
anna.ghambaryan@nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.271, 
Alcohol Research Career Development Awards for Scientists and 
Clinicians; 93.272, Alcohol National Research Service Awards for 
Research Training; 93.273, Alcohol Research Programs; 93.891, 
Alcohol Research Center Grants; 93.701, ARRA Related Biomedical 
Research and Research Support Awards., National Institutes of 
Health, HHS).

    Dated: October 5, 2017.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2017-21989 Filed 10-11-17; 8:45 am]
BILLING CODE 4140-01-P

Federal Register / Vol. 82, No. 196 / Thursday, October 12, 2017 / Notices 47537

ANNUALIZED BURDEN HOUR TABLE
Number of Average Total
Number of
Forms Respondents responses per burden per burden
respondents respondents response hours

Advocate Form ................................. Site Coordinator .............................. 10 1 20/60 3
Advocate Annual Follow-Up Survey Site Coordinator .............................. 10 1 20/60 3
End of Wave 1 Interview Script ....... Site Coordinator .............................. 10 1 1 10
End of Wave 1 Feedback Survey .... Site Coordinator .............................. 10 1 45/60 8
End of Wave 2 Interview ................. Site Coordinator .............................. 10 1 1 10
End of Wave 2 Feedback Survey .... Site Coordinator .............................. 10 1 20/60 3
Technical Assistance Assessment .. Site Coordinator .............................. 10 1 25/60 4
Mentee Pre-Assessment .................. Mentee/Program Participant ............ 700 1 20/60 233
Mentee Post-Assessment ................ Mentee/Program Participant ............ 700 1 20/60 233
Mentor Feedback Survey ................. Mentor ............................................. 700 1 15/60 175
Weekly Goal-Setting Guide ............. Mentor ............................................. 700 10 10/60 1166
Mentee Focus Group Script ............. Mentee/Program Participant ............ 60 1 1 60
Parent/Guardian Focus Group Mentee’s Parent/Guardian .............. 60 1 1 60
Script.

Total .......................................... .......................................................... ........................ 22 ........................ 1968

Terry S. Clark, Abuse and Alcoholism, National Institutes of DEPARTMENT OF HEALTH AND
Office of the Secretary, Asst Paperwork Health, 5635 Fishers Lane, Room 2109, HUMAN SERVICES
Reduction Act Reports Clearance Officer. Rockville, MD 20852 301–443–8599,
[FR Doc. 2017–21983 Filed 10–11–17; 8:45 am] rippera@mail.nih.gov. National Institutes of Health
BILLING CODE 4150–35–P This notice is being published less than 15
days prior to the meeting due to the timing Prospective Grant of Exclusive Patent
limitations imposed by the review and License: DNA-Based Vaccine for
DEPARTMENT OF HEALTH AND funding cycle. Prevention of Zika Virus Infection
HUMAN SERVICES Name of Committee: National Institute on
AGENCY: National Institutes of Health,
Alcohol Abuse and Alcoholism Special
National Institutes of Health Department of Health and Human
Emphasis Panel, SEP Review Member
Services.
Conflict Applications.
National Institute on Alcohol Abuse Date: November 14, 2017. ACTION: Notice.
and Alcoholism; Notice of Closed Time: 2:00 p.m. to 4:00 p.m.
Meetings Agenda: To review and evaluate grant SUMMARY: The National Institute of
applications. Allergy and Infectious Diseases (NIAID),
Pursuant to section 10(d) of the an institute of the National Institutes of
Place: National Institutes of Health,
Federal Advisory Committee Act, as Health, Department of Health and
National Institute on Alcohol Abuse and
amended, notice is hereby given of the Human Services, is contemplating the
Alcoholism, 5635 Fishers Lane, Rockville,
following meetings. grant of an Exclusive Commercialization
MD 20892 (Telephone Conference Call).
The meetings will be closed to the Patent License to PaxVax, Inc., located
Contact Person: Anna Ghambaryan, M.D.,
public in accordance with the Scientific Review Officer, Office of in Redwood City, California, to practice
provisions set forth in sections Extramural Activities, National Institute on the inventions embodied in the patent
552b(c)(4) and 552b(c)(6), Title 5 U.S.C., Alcohol Abuse and Alcoholism, National applications listed in the
as amended. The grant applications and Institutes of Health, 5635 Fishers Lane, SUPPLEMENTARY INFORMATION section of
the discussions could disclose Rockville, MD 20852, 301–443–4032, this notice.
confidential trade secrets or commercial anna.ghambaryan@nih.gov. DATES: Only written comments and/or
property such as patentable material,
(Catalogue of Federal Domestic Assistance applications for a license which are
and personal information concerning
Program Nos. 93.271, Alcohol Research received by the National Institute of
individuals associated with the grant
Career Development Awards for Scientists Allergy and Infectious Diseases’
applications, the disclosure of which
and Clinicians; 93.272, Alcohol National Technology Transfer and Intellectual
would constitute a clearly unwarranted Research Service Awards for Research
invasion of personal privacy. Property Office on or before November
Training; 93.273, Alcohol Research Programs; 13, 2017 will be considered.
Name of Committee: National Institute on 93.891, Alcohol Research Center Grants;
Alcohol Abuse and Alcoholism, Special ADDRESSES: Requests for copies of the
93.701, ARRA Related Biomedical Research
Emphasis Panel; NIAAA Fellowship Review. patent applications, inquiries, and
and Research Support Awards., National
Date: November 2, 2017. Institutes of Health, HHS).
comments relating to the contemplated
Time: 8:30 a.m. to 6:00 p.m. Exclusive Commercialization Patent
Dated: October 5, 2017.
asabaliauskas on DSKBBXCHB2PROD with NOTICES

Agenda: To review and evaluate grant License should be directed to: Dr. Amy
applications. Melanie J. Pantoja, Petrik, Technology Transfer and Patent
Place: National Institutes of Health, Specialist, Technology Transfer and
Program Analyst, Office of Federal Advisory
National Institute on Alcohol Abuse and Intellectual Property Office, National
Alcoholism, Terrace Conference Room, 5635 Committee Policy.
Fishers Lane, Bethesda, MD 20892. [FR Doc. 2017–21989 Filed 10–11–17; 8:45 am] Institute of Allergy and Infectious
Contact Person: Richard A. Rippe, Ph.D., BILLING CODE 4140–01–P
Diseases, 5601 Fishers Lane, Suite 2G,
Scientific Review Officer, Extramural Project MSC9804, Rockville, MD 20852–9804,
Review Branch, Office of Extramural phone number 301–496–2644, or
Activities, National Institute on Alcohol petrika@mail.nih.gov.

VerDate Sep<11>2014 22:35 Oct 11, 2017 Jkt 244001 PO 00000 Frm 00092 Fmt 4703 Sfmt 4703 E:\FR\FM\12OCN1.SGM 12OCN1

Document Created: 2018-10-25 10:03:39
Document Modified: 2018-10-25 10:03:39

Category		Regulatory Information
Collection		Federal Register
sudoc Class		AE 2.7: GS 4.107: AE 2.106:
Publisher		Office of the Federal Register, National Archives and Records Administration
Section		Notices
Dates		November 2, 2017.
FR Citation		82 FR 47537

82 FR 47537 - National Institute on Alcohol Abuse and Alcoholism; Notice of Closed Meetings

DEPARTMENT OF HEALTH AND HUMAN SERVICESNational Institutes of Health

Federal Register Volume 82, Issue 196 (October 12, 2017)

DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health